Options Brief: Arena Pharmaceuticals

Shares of Arena Pharmaceuticals ARNA are lower on the session by 1.98%, trading at $1.48. Overall call volume is now running at 2.48x the daily average, with 60% of all calls traded being purchases on the offer. 1,427 contracts have traded on the session so far. Arena Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs that target G protein-coupled receptors, in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.